Ducibella T, LeFevre L
Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Mol Reprod Dev. 1997 Feb;46(2):216-26. doi: 10.1002/(SICI)1098-2795(199702)46:2<216::AID-MRD12>3.0.CO;2-Z.
Although pharmacological agonists of protein kinase C (PKC) stimulate some events of mammalian egg activation, including cortical granule (CG) exocytosis, it is not known if these events are dependent on PKC activation during the normal process of fertilization. In order to examine the potential role of PKC in CG exocytosis, this study investigated whether PKC agonists faithfully mimic CG release and whether PKC antagonists block fertilization-induced CG release in mature mouse eggs. Phorbol ester (TPA, 2.5 ng/ml) treatment resulted in an atypical pattern of CG release in which there was a greater net loss of CGs in the equatorial region of the egg than in the region opposite the spindle. This pattern also was in contrast to that during fertilization, in which CG release occurred randomly throughout the cortex. Fertilization experiments utilized two different PKC inhibitors, bisindolylmaleimide (5 microM) and chelerytherine (0.8 microM), targeted to both the "conserved" substrate and ATP binding domains of PKC. Simultaneous use of both inhibitors at maximal concentrations (compatible with fertilization and above their IC50S) resulted in no detectable inhibition of CG release in treated fertilized eggs compared to controls. In addition no inhibition of anaphase onset was observed in treated fertilized eggs. Activity of the inhibitors was verified by demonstrating that they blocked the induction of CG loss by TPA. Moreover, 1 microM staurosporine, a potent but less specific antagonist of PKC, also did not block CG loss whereas the metaphase-anaphase transition was temporarily inhibited. The results indicate that TPA does not faithfully mimic CG release in fertilized eggs, that a role for PKC in CG release at fertilization remains to be established, and that other calcium-dependent effectors may be involved in CG exocytosis.
尽管蛋白激酶C(PKC)的药理学激动剂可刺激哺乳动物卵子激活的某些事件,包括皮质颗粒(CG)胞吐作用,但尚不清楚这些事件在正常受精过程中是否依赖于PKC激活。为了研究PKC在CG胞吐作用中的潜在作用,本研究调查了PKC激动剂是否能如实地模拟CG释放,以及PKC拮抗剂是否能阻断成熟小鼠卵子中受精诱导的CG释放。佛波酯(TPA,2.5 ng/ml)处理导致CG释放的非典型模式,即卵子赤道区域的CG净损失比纺锤体对面区域更大。这种模式也与受精期间的模式形成对比,受精时CG释放在整个皮质随机发生。受精实验使用了两种不同的PKC抑制剂,双吲哚马来酰胺(5 microM)和白屈菜红碱(0.8 microM),它们靶向PKC的“保守”底物和ATP结合域。与对照组相比,在最大浓度(与受精相容且高于其IC50)同时使用这两种抑制剂,未观察到对处理过的受精卵中CG释放的可检测抑制。此外,在处理过的受精卵中未观察到后期开始的抑制。通过证明它们阻断TPA诱导的CG损失来验证抑制剂的活性。此外,1 microM星形孢菌素是一种强效但特异性较低的PKC拮抗剂,也未阻断CG损失,而中期-后期转换被暂时抑制。结果表明,TPA不能如实地模拟受精卵中的CG释放,PKC在受精时CG释放中的作用仍有待确定,并且其他钙依赖性效应器可能参与CG胞吐作用。